☰

Ruth A. Keri

Affiliations: 
Pharmacology Case Western Reserve University, Cleveland Heights, OH, United States 
Area:
Pharmacology, Oncology, Cell Biology
Google:
"Ruth Keri"
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Erin L. Milliken grad student 2005 Case Western
Melissa D. Landis grad student 2006 Case Western
Gina M. Gernardo grad student 2011 Case Western
Jennifer L. Yori grad student 2011 Case Western

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Caputo A, Vipparthi K, Bazeley P, et al. (2023) Spatial transcriptomics suggests that alterations occur in the preneoplastic breast microenvironment of BRCA1/2 mutation carriers. Molecular Cancer Research : McR
Kao HY, Pai CP, Wang H, et al. (2023) The PML1-WDR5 axis regulates H3K4me3 marks and promotes stemness of estrogen receptor-positive breast cancer. Research Square
Bobbitt JR, Seachrist D, Keri RA. (2023) Chromatin organization and transcriptional programming of breast cancer cell identity. Endocrinology
Caputo A, Vipparthi K, Bazeley P, et al. (2023) Alterations in the preneoplastic breast microenvironment of mutation carriers revealed by spatial transcriptomics. Biorxiv : the Preprint Server For Biology
Anstine LJ, Majmudar PR, Aponte A, et al. (2023) TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis. Cancer Research
Cuellar-Vite L, Weber-Bonk KL, Abdul-Karim FW, et al. (2022) Focal Adhesion Kinase Provides a Collateral Vulnerability That Can Be Leveraged to Improve mTORC1 Inhibitor Efficacy. Cancers. 14
Seachrist DD, Anstine LJ, Keri RA. (2021) FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer. Cancers. 13
Piemonte KM, Anstine LJ, Keri RA. (2021) Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer. Endocrinology. 162
Webb BM, Bryson BL, Williams-Medina E, et al. (2021) TGF-β/Activin Signaling Promotes CDK7 Inhibitor Resistance in Triple Negative Breast Cancer Cells through Upregulation of Multidrug Transporters. The Journal of Biological Chemistry. 101162
Adorno-Cruz V, Hoffmann AD, Liu X, et al. (2021) promotes expression of and in enhancing breast cancer stemness and metastasis. Genes & Diseases. 8: 493-508
See more...